"The decision to create three independent, public companies means more career opportunities as we will need outstanding teams to set each company up for success." ...
The S&P 500 rose 0.4% following healthy gains for stock markets across much ... treatments is swelling its profits. Honeywell fell 5.6% and was one of the heaviest weights on the S&P 500. It announced ...
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback